Neurotech: Neurotech Pharmaceuticals, Inc. and Lowy Medical Research Institute Announce Publication of NT-501 Phase 2 Results

CUMBERLAND, Rhode Island, and LA JOLLA, California, Jan. 16, 2019 /PRNewswire/ -- The results of the NT-501 Phase 2 study sponsored by Neurotech Pharmaceuticals, Inc. (Neurotech) in collaboration ...